Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer. 2016 Jun 2;122(15):2426–2439. doi: 10.1002/cncr.30072

Table 4.

Participation rates by race and ethnicity among selected NIH-funded cohorts and survey-based cancer survivor studies

Participation rates by race and ethnicity among NIH funded cohort studies*
Recruitment Methodology Eligible (N) Participating (N, % of Eligible)
Cohort size Hispanic Non-Hispanic white Non-Hispanic black Asian/Pacific Islander Native American
Childhood Cancer Survivor Study (CCSS, Expanded Cohort) US Mail/phone 15,233 10,004 (66%) 1,063 (67%) 7615 (70%) 842 (57%) 198 (61%)
The Multiethnic Cohort (MEC)44 US Mail 854,613 218,780 (30%) 281,990 (17%) 136,142 (34%) 170,694 (21%) 137,812 (44%)
Adventist Health Study 2 (AHS-2)45,46 Community-based 350,000 96,163 (28%) 71,865 (28%) 25,087 (28%)
Genetic and Epidemiology Study of Cardiovascular Disease in Alaska Natives (GOCADAN)47,48 Community-based 7,7000 1,214 (74%) 1,214 (74%)
Jackson Heart Study (JHS)49 Community-based 76,420 5,302 (51%) 5,302 (51%)
National Health and Nutrition Examination Survey II (NHANES II)50 27,801 25,286 (91%) 21,359 (91%) 3,389 (93%)
National Health and Nutrition Examination Survey III (NHANES III)51 39.695 33,994# (82%) 9,751 (87%) 13,085 (80%) 9,627 (86%)
Strong Heart Study (SHS, American Indian)52 Community-based 7,305 4,529# (62%) 4,529# (62%)
Participation rates by race and ethnicity among NIH funded, survey-based cancer survivor studiesˆ
Recruitment Methodology Eligible (N) Participating (N, % of Eligible)
TOTAL Hispanic White, Non-Hispanic Black, Non-Hispanic Asian/Pacific Islander Native American
Childhood Cancer Survivor Study (CCSS, Expanded Cohort) US Mail/phone 15,233 10,004 (66%) 1,063 (67%) 7615 (70%) 842 (57%) 198 (61%)
Project Forward Study53 US Mail 470 235 (50%) 121 (49%) 80 (58%)
Adolescent and Young Adult Health Outcomes and Patient Experience Study (AYA-HOPE)54 US Mail/phone/internet 1,208 524 (43%) 97 (35%) 331 (47%) 42 (38%)
Experience of Care and Health Outcomes of Survivors of Non-Hodgkin Lymphoma (ECHOS-NHL)55 US Mail 744 408 (55%) 89 (45%) 290 (59%) 29 (49%)
Health, Eating, Activity and Lifestyle Study (HEAL)56 US Mail/In-person Interview 3,070 856 (29%) 429 (37%) 671 (27%) 1 (2%) 14 (19%)
*

Additional NIH funded cohorts not reporting participation rates by race/ethnicity, most commonly by not providing % eligible by race/ethnicity5783,85,86

#

% of eligible, as number contacted is not known